サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768797

自動輸血システムの世界市場

Autotransfusion Systems

出版日
ページ情報
英文 144 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
自動輸血システムの世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 144 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自動輸血システムの世界市場は2030年までに4億6,770万米ドルに達する見込み

2024年に3億6,650万米ドルと推定される自動輸血システムの世界市場は、2030年には4億6,770万米ドルに達し、分析期間2024-2030年のCAGRは4.1%で成長すると予測されます。本レポートで分析したセグメントの1つである自己輸血製品は、CAGR 4.5%を記録し、分析期間終了時には3億3,620万米ドルに達すると予測されます。自動輸血アクセサリー分野の成長率は、分析期間中CAGR 3.3%と推定されます。

米国市場は1億20万米ドルと推定、中国はCAGR4.0％で成長予測

米国の自動輸血システム市場は、2024年に1億20万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに7,470万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.9％と3.5％と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界の自動輸血システム市場- 主要動向と促進要因のまとめ

自動輸血システムとは何か、そして自動輸血システムは外科手術における血液管理をどのように変革しているのか？

自動輸血システムは、手術中に患者自身の血液を収集、ろ過、返血するように設計された医療機器であり、手術室や外傷環境における血液管理方法を変革します。従来、手術中に血液を必要とする患者はドナーからの輸血に頼っていたが、この輸血には免疫反応、感染症、適合する血液型が限られているなどのリスクがありました。自己血輸血、あるいは細胞サルベージは、手術中に失われた患者自身の血液を採取し、濾過して不純物をきれいにしてから患者に再注入します。このプロセスにより、ドナー血液への依存を減らし、輸血反応や血液感染症の伝播のリスクを最小限に抑えることができます。自動輸血システムは、心臓、整形外科、血管処置などの大量出血を伴う手術や、外傷治療において特に有用です。技術の進歩に伴い、自動輸血システムはより効果的でコンパクトになり、救急救命室や戦場医療など、より幅広い臨床現場で利用できるようになりました。患者自身の血液を利用することで、これらのシステムは従来の輸血に代わる、より安全で効率的、かつ費用対効果の高い選択肢を提供し、患者の転帰を向上させ、血液保存における新たな基準を打ち立てます。

自動輸血システムは様々な医療分野でどのように活用されていますか？

自動輸血システムの多用途性は、様々な医療専門分野での採用につながっており、それぞれがユニークな外科手術や救急治療のニーズを満たすためにこの技術を活用しています。出血量が多い心臓血管外科手術では、自動輸血システムは安定した血液量とヘモグロビンレベルを維持し、同種（ドナー）輸血の必要性を減らします。これは、開心術や動脈瘤の修復のような複雑な手術では特に重要であり、血液供給が少しでも減少すると深刻な結果を招く可能性があります。整形外科手術もまた、自動輸血システムが重要な役割を果たす分野であり、特に関節置換術や脊椎手術では、かなりの出血を伴うことがあります。自己血輸血は輸血反応のリスクを最小限に抑え、異物である血液製剤を避けることでより早い回復をサポートします。迅速な対応が重要な外傷や救急医療において、自動輸血システムは、ドナー血液がすぐに入手できないような状況でも、臨床医が患者を安定させることを可能にします。産科医療では、自動輸血システムは分娩後出血の症例に使用することができ、大量出血時の母子のリスクを軽減することができます。自動輸血システムの適応性の高さは、患者の安全性を高め、転帰を改善し、医療従事者が手術や緊急時の血液管理をよりコントロールできるようにする、多様な臨床現場での貴重な存在となっています。

自動輸血システムの普及にはどのような課題がありますか？

自動輸血システムは多くの利点を提供しますが、広く普及するためにはいくつかの課題を克服しなければなりません。主な検討事項のひとつはコストです。自動輸血装置は入手と維持に費用がかかるため、リソースが限られている小規模のクリニックや病院では利用しにくいです。さらに、これらのシステムの操作には訓練を受けたスタッフが必要であり、特に農村部や資源不足の地域では、すべてのヘルスケア環境に必要な専門知識を持ったスタッフがいるわけではないです。自己血輸血は、あらゆる種類の手術や、感染症や悪性腫瘍など特定の病態を持つ患者には適しておらず、救済された血液を再輸血することは危険です。また、血液中に汚染物質が残っていると副作用を引き起こす可能性があるため、再輸血の安全性を確保するために血液のろ過や処理を正確に行う必要があることから、技術的課題も生じる。さらに、自己輸血の使用にまつわる文化的・患者固有の懸念もあり、ある種の患者は、体外に出た自分の血液を受け取ることに消極的であったり、個人的な信条を表明したりするため、自己輸血が受け入れられるためのさらなる障壁となっています。このような経済的、臨床的、物流的な課題を克服するには、的を絞ったトレーニングプログラム、コスト効率と使いやすさを向上させる技術の進歩、自己輸血の安全性と有効性について医療従事者と患者の双方を教育する努力が必要です。

自己輸血システム市場の成長を支える主な要因とは？

自動輸血システム市場は、医療技術の進歩、血液保存に対する意識の高まり、高出血を伴う複雑な手術の有病率の増加などを背景に、顕著な成長を遂げています。技術革新は、大病院から小規模クリニックまで、より幅広い手術環境に組み込むことができる、よりコンパクトで効率的、かつユーザーフレンドリーな自動輸血システムの開発につながりました。この多用途性により、心臓血管外科、整形外科、外傷外科を含む複数の外科分野にわたって自己輸血の可能性が広がっています。さらに、患者の安全性と輸血関連合併症の減少にますます焦点が当てられるようになったことで、ヘルスケアプロバイダーは血液を節約し、ドナー供給への依存度を下げる方法を採用するようになりました。世界の血液供給不足と輸血伝染性感染症の懸念がある中、自己輸血はドナー血液の需要を減らす信頼できる代替手段を提供し、安全性と準備態勢を向上させるという病院の目標に合致しています。特に先進諸国では高齢化が進んでおり、手術を受ける高齢の患者が同種輸血のリスクを高める疾患を抱えている可能性があるため、自己輸血が望ましい選択肢となっていることも一因となっています。さらに、規制やヘルスケアのガイドラインは、特に患者中心の費用対効果の高い医療を重視する国々では、自己輸血を含む血液管理戦略を重視するようになっています。技術の進歩、より安全な輸血への需要の高まり、人口動態の変化、規制当局の支援など、これらの要因が交錯することで、自己輸血市場の成長が促進され、現代ヘルスケアにおける価値あるソリューションとして確固たる地位を築いています。

セグメント

製品タイプ（自己輸血製品、自己輸血アクセサリー）、用途（心臓血管外科、整形外科、産科・婦人科外科、神経外科、その他の用途）

調査対象企業の例

  • Atrium Medical Corporation（A Part of Getinge Group）
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomedica
  • Fresenius Medical Care AG & Co. KGaA
  • Gen World Medical Devices
  • Haemonetics Corporation
  • Livanova PLC
  • Medtronic PLC
  • Redax

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP21289

Global Autotransfusion Systems Market to Reach US$467.7 Million by 2030

The global market for Autotransfusion Systems estimated at US$366.5 Million in the year 2024, is expected to reach US$467.7 Million by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Autotransfusion Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$336.2 Million by the end of the analysis period. Growth in the Autotransfusion Accessories segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$100.2 Million While China is Forecast to Grow at 4.0% CAGR

The Autotransfusion Systems market in the U.S. is estimated at US$100.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$74.7 Million by the year 2030 trailing a CAGR of 4.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Autotransfusion Systems Market - Key Trends and Drivers Summarized

What Are Autotransfusion Systems, and How Are They Transforming Blood Management in Surgery?

Autotransfusion systems are medical devices designed to collect, filter, and return a patient’s own blood during surgery, transforming how blood is managed in operating rooms and trauma settings. Traditionally, patients requiring blood during surgery have relied on donor blood transfusions, which can introduce risks such as immune reactions, infections, and limited availability of compatible blood types. Autotransfusion, or cell salvage, allows for the collection of a patient’s own blood that is lost during surgery, filtering and cleaning it of impurities before reinfusing it back into the patient. This process reduces dependence on donor blood and minimizes the risk of transfusion reactions and transmission of bloodborne diseases. Autotransfusion systems are particularly valuable in surgeries involving significant blood loss, such as cardiac, orthopedic, and vascular procedures, as well as in trauma care. As technology advances, autotransfusion systems have become more effective and compact, making them accessible in a wider range of clinical settings, including emergency rooms and battlefield medicine. By utilizing the patient’s own blood, these systems provide a safer, more efficient, and cost-effective alternative to traditional transfusions, enhancing patient outcomes and setting new standards in blood conservation.

How Are Autotransfusion Systems Being Utilized Across Different Medical Specialties?

The versatility of autotransfusion systems has led to their adoption across various medical specialties, each leveraging this technology to meet unique surgical and emergency care needs. In cardiovascular surgery, where blood loss can be significant, autotransfusion systems help maintain stable blood volume and hemoglobin levels, reducing the need for allogeneic (donor) blood transfusions. This is especially important in complex procedures such as open-heart surgeries or aneurysm repairs, where even a small reduction in blood supply can have serious consequences. Orthopedic surgery is another area where autotransfusion systems play a vital role, particularly in joint replacements and spinal surgeries that may involve considerable blood loss. Autotransfusion minimizes the risk of transfusion reactions and supports faster recovery by avoiding foreign blood products. In trauma and emergency care, where rapid response is critical, autotransfusion systems allow clinicians to stabilize patients in situations where donor blood may not be immediately available. In obstetric care, autotransfusion systems can be used in cases of postpartum hemorrhage, reducing the risk to mother and child when blood loss is substantial. The adaptability of autotransfusion systems makes them invaluable in diverse clinical settings, where they enhance patient safety, improve outcomes, and offer healthcare providers greater control over blood management in surgeries and emergencies.

What Challenges Do Autotransfusion Systems Face in Widespread Adoption?

While autotransfusion systems offer numerous benefits, several challenges must be overcome to achieve broader adoption. One major consideration is cost, as autotransfusion equipment can be expensive to acquire and maintain, making it less accessible for smaller clinics and hospitals with limited resources. Additionally, the operation of these systems requires trained personnel, and not all healthcare settings have staff with the necessary expertise, particularly in rural or under-resourced areas. Clinical limitations are another factor; autotransfusion is not suitable for all types of surgeries or for patients with certain conditions, such as infections or malignancies, where reinfusing salvaged blood may pose a risk. Technical challenges also arise from the need for precision in filtering and processing blood to ensure it is safe for reinfusion, as any contaminants left in the blood could cause adverse reactions. Furthermore, some cultural and patient-specific concerns surround the use of autotransfusion, with certain patients expressing reluctance or personal beliefs against receiving their own blood if it has left the body, presenting an additional barrier to its acceptance. Overcoming these economic, clinical, and logistical challenges requires targeted training programs, technological advancements to improve cost efficiency and usability, and efforts to educate both medical professionals and patients on the safety and efficacy of autotransfusion.

What Major Factors Are Behind the Growth of the Autotransfusion System Market?

The autotransfusion system market is experiencing notable growth, driven by advancements in medical technology, rising awareness of blood conservation, and the increasing prevalence of complex surgeries with high blood loss. Technological innovations have led to the development of more compact, efficient, and user-friendly autotransfusion systems that can be integrated into a wider variety of surgical environments, from large hospitals to smaller clinics. This versatility has expanded the potential for autotransfusion across multiple surgical fields, including cardiovascular, orthopedic, and trauma surgery. Furthermore, the growing focus on patient safety and reducing transfusion-related complications has spurred healthcare providers to adopt methods that conserve blood and lower dependence on donor supplies. With shortages in the global blood supply and concerns about transfusion-transmissible infections, autotransfusion offers a reliable alternative that reduces demand for donor blood, aligning with hospitals’ goals to improve safety and preparedness. The increase in aging populations, especially in developed countries, is also a factor, as older patients undergoing surgery may have conditions that make allogeneic transfusions riskier, making autotransfusion a preferred choice. Additionally, regulatory and healthcare guidelines now emphasize blood management strategies that include autotransfusion, particularly in countries focused on patient-centered and cost-effective care. These intersecting factors-technological advances, rising demand for safer transfusions, demographic changes, and regulatory support-are propelling the growth of the autotransfusion market, cementing it as a valuable solution in modern healthcare.

SCOPE OF STUDY:

The report analyzes the Autotransfusion Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Autotransfusion Products, Autotransfusion Accessories); Application (Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Atrium Medical Corporation (A Part of Getinge Group)
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomedica
  • Fresenius Medical Care AG & Co. KGaA
  • Gen World Medical Devices
  • Haemonetics Corporation
  • Livanova PLC
  • Medtronic PLC
  • Redax

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Autotransfusion Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Blood Conservation Drives Growth in Autotransfusion Systems Market
    • Increasing Use of Autotransfusion in Cardiac and Orthopedic Surgeries Expands Market Applications
    • Here's How Advances in Autotransfusion Technology Improve Blood Recovery Efficiency
    • Growing Focus on Patient Safety Supports Adoption of Autotransfusion to Reduce Transfusion-Related Risks
    • Rising Incidence of Complex Surgeries Fuels Demand for Reliable Autotransfusion Systems
    • Increasing Emphasis on Minimally Invasive Procedures Drives Need for Compact Autotransfusion Devices
    • Here's How Autotransfusion Systems Enhance Blood Management in Trauma and Emergency Care
    • Advancements in Filtration Technology Improve Quality and Safety of Recycled Blood
    • Growing Adoption of Autotransfusion Systems in Military and Disaster Medicine Expands Market Scope
    • Here's How Increased Awareness of Blood-Borne Diseases Fuels Demand for Closed Autotransfusion Systems
    • Rising Demand for Blood Management Solutions in Developing Countries Supports Market Growth
    • Focus on Reducing Blood Supply Shortages Drives Adoption of Autotransfusion in Major Hospitals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Autotransfusion Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Autotransfusion Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Autotransfusion Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Autotransfusion Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Orthopedic Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Orthopedic Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Autotransfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiovascular Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiovascular Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Obstetrics & Gynecological Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Obstetrics & Gynecological Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurological Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Neurological Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • CHINA
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030

IV. COMPETITION